JP2006522812A - 複素環mchr1アンタゴニスト - Google Patents
複素環mchr1アンタゴニスト Download PDFInfo
- Publication number
- JP2006522812A JP2006522812A JP2006509727A JP2006509727A JP2006522812A JP 2006522812 A JP2006522812 A JP 2006522812A JP 2006509727 A JP2006509727 A JP 2006509727A JP 2006509727 A JP2006509727 A JP 2006509727A JP 2006522812 A JP2006522812 A JP 2006522812A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- compound
- mmol
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000623 heterocyclic group Chemical group 0.000 title claims abstract description 43
- 239000005557 antagonist Substances 0.000 title abstract description 10
- 101000581402 Homo sapiens Melanin-concentrating hormone receptor 1 Proteins 0.000 title description 8
- 102100027375 Melanin-concentrating hormone receptor 1 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 341
- 238000000034 method Methods 0.000 claims abstract description 86
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 13
- -1 C 1 -C 3 alkyl Chemical group 0.000 claims description 210
- 238000006243 chemical reaction Methods 0.000 claims description 103
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 65
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 64
- 229910052757 nitrogen Inorganic materials 0.000 claims description 62
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 61
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 57
- 229910052739 hydrogen Inorganic materials 0.000 claims description 50
- 239000001257 hydrogen Substances 0.000 claims description 49
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 48
- 125000005843 halogen group Chemical group 0.000 claims description 46
- 125000000217 alkyl group Chemical group 0.000 claims description 44
- 239000002904 solvent Substances 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 40
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 38
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 38
- 125000003118 aryl group Chemical group 0.000 claims description 37
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 37
- 125000001424 substituent group Chemical group 0.000 claims description 36
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 31
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 30
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 28
- 150000002431 hydrogen Chemical class 0.000 claims description 25
- 229910052763 palladium Inorganic materials 0.000 claims description 24
- 229910052717 sulfur Inorganic materials 0.000 claims description 24
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 21
- 229910052799 carbon Inorganic materials 0.000 claims description 20
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 20
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 20
- 125000001072 heteroaryl group Chemical group 0.000 claims description 19
- 125000004043 oxo group Chemical group O=* 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 125000003282 alkyl amino group Chemical group 0.000 claims description 18
- 208000008589 Obesity Diseases 0.000 claims description 17
- 150000001412 amines Chemical class 0.000 claims description 17
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 17
- 235000020824 obesity Nutrition 0.000 claims description 17
- 239000012453 solvate Substances 0.000 claims description 16
- 241000124008 Mammalia Species 0.000 claims description 15
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 15
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 14
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 14
- 125000004414 alkyl thio group Chemical group 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 11
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims description 10
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 10
- 206010012601 diabetes mellitus Diseases 0.000 claims description 10
- 125000005842 heteroatom Chemical group 0.000 claims description 10
- 125000002619 bicyclic group Chemical group 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 208000019901 Anxiety disease Diseases 0.000 claims description 7
- 230000036506 anxiety Effects 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 7
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 6
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims description 6
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 239000011593 sulfur Substances 0.000 claims description 5
- YMDKGGMAMAEFNG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=C2N(C)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 YMDKGGMAMAEFNG-UHFFFAOYSA-N 0.000 claims description 4
- UODVREUPOUDRNR-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-(pyrrolidin-1-ylmethyl)naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCC4)=CC3=CC=1)C=N2 UODVREUPOUDRNR-UHFFFAOYSA-N 0.000 claims description 4
- HTLJHDQWVDIZCQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-[(4-hydroxypiperidin-1-yl)methyl]naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1CC(O)CCN1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=C1 HTLJHDQWVDIZCQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000556 agonist Substances 0.000 claims description 4
- 229910052786 argon Inorganic materials 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000003367 polycyclic group Chemical group 0.000 claims description 4
- 229910052727 yttrium Inorganic materials 0.000 claims description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 3
- XYCZXPVVNCEPEF-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-methylpiperazin-1-yl)methyl]-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1CC1=CC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2S1 XYCZXPVVNCEPEF-UHFFFAOYSA-N 0.000 claims description 3
- ATILBCJMFACSLA-UHFFFAOYSA-N 6-phenyl-3-[2-(pyrrolidin-1-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound S1C=2C(=O)N(C=3C=C4C=CC(CN5CCCC5)=NC4=CC=3)C=NC=2C=C1C1=CC=CC=C1 ATILBCJMFACSLA-UHFFFAOYSA-N 0.000 claims description 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 125000001475 halogen functional group Chemical group 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 claims description 3
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims description 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 2
- FDIBWJRZRJTTOK-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(2-methyl-4,5-dihydroimidazol-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound CC1=NCCN1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=N1 FDIBWJRZRJTTOK-UHFFFAOYSA-N 0.000 claims description 2
- SANXLPAIECKXLI-UHFFFAOYSA-N 6-(4-fluorophenyl)-3-[2-(piperidin-1-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCCC4)=NC3=CC=1)C=N2 SANXLPAIECKXLI-UHFFFAOYSA-N 0.000 claims description 2
- 229940124802 CB1 antagonist Drugs 0.000 claims description 2
- 108010016122 Ghrelin Receptors Proteins 0.000 claims description 2
- 102100039256 Growth hormone secretagogue receptor type 1 Human genes 0.000 claims description 2
- 101000993364 Homo sapiens Ciliary neurotrophic factor Proteins 0.000 claims description 2
- 101000978418 Homo sapiens Melanocortin receptor 4 Proteins 0.000 claims description 2
- 229940086609 Lipase inhibitor Drugs 0.000 claims description 2
- 102100023724 Melanocortin receptor 4 Human genes 0.000 claims description 2
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- 238000006619 Stille reaction Methods 0.000 claims description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 229940125425 inverse agonist Drugs 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 230000001561 neurotransmitter reuptake Effects 0.000 claims description 2
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 claims description 2
- 239000000018 receptor agonist Substances 0.000 claims description 2
- 229940044601 receptor agonist Drugs 0.000 claims description 2
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 claims 4
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical group C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 claims 2
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 claims 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 claims 2
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 claims 2
- HJFIRBMYMDXWII-UHFFFAOYSA-N 6-(4-fluorophenyl)-3-[2-(pyrrolidin-1-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCC4)=NC3=CC=1)C=N2 HJFIRBMYMDXWII-UHFFFAOYSA-N 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- 239000013626 chemical specie Substances 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 5
- 108091008039 hormone receptors Proteins 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 363
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 230
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 182
- 239000000203 mixture Substances 0.000 description 180
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 167
- 239000007787 solid Substances 0.000 description 145
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 109
- 239000000243 solution Substances 0.000 description 101
- 239000000460 chlorine Substances 0.000 description 97
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 86
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 74
- 239000000543 intermediate Substances 0.000 description 72
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 69
- 235000019439 ethyl acetate Nutrition 0.000 description 66
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 54
- 238000002474 experimental method Methods 0.000 description 48
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 46
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- 239000000047 product Substances 0.000 description 40
- 239000011541 reaction mixture Substances 0.000 description 39
- 239000000741 silica gel Substances 0.000 description 38
- 229910002027 silica gel Inorganic materials 0.000 description 38
- 235000002639 sodium chloride Nutrition 0.000 description 37
- 238000010992 reflux Methods 0.000 description 34
- 239000002244 precipitate Substances 0.000 description 32
- 238000010898 silica gel chromatography Methods 0.000 description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000000706 filtrate Substances 0.000 description 27
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 26
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 22
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 22
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 21
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 21
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 20
- 230000002829 reductive effect Effects 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 238000002953 preparative HPLC Methods 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 13
- 229910021529 ammonia Inorganic materials 0.000 description 13
- 239000012267 brine Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000004440 column chromatography Methods 0.000 description 12
- 239000012043 crude product Substances 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 11
- 235000019253 formic acid Nutrition 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- ALWFLYMKFZJTBB-RQZCQDPDSA-N CN(C)/C=N/C1=C(C(=O)OC)SC(C=2C=CC(Cl)=CC=2)=C1 Chemical compound CN(C)/C=N/C1=C(C(=O)OC)SC(C=2C=CC(Cl)=CC=2)=C1 ALWFLYMKFZJTBB-RQZCQDPDSA-N 0.000 description 10
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 238000004587 chromatography analysis Methods 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 9
- 238000003818 flash chromatography Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 9
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 8
- 0 CC(C)(C=C(C=C1)NC)C=C1N(C(*)=NC(I)=C1*)C1=O Chemical compound CC(C)(C=C(C=C1)NC)C=C1N(C(*)=NC(I)=C1*)C1=O 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 101800002739 Melanin-concentrating hormone Proteins 0.000 description 8
- 239000012298 atmosphere Substances 0.000 description 8
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 7
- 102000044674 Melanin-concentrating hormone receptor 1 Human genes 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 229940098779 methanesulfonic acid Drugs 0.000 description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 125000002947 alkylene group Chemical group 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 6
- 238000002390 rotary evaporation Methods 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- KXMTWHCGFNZHTG-UHFFFAOYSA-N 2-chloro-1-methyl-6-nitrobenzimidazole Chemical compound C1=C([N+]([O-])=O)C=C2N(C)C(Cl)=NC2=C1 KXMTWHCGFNZHTG-UHFFFAOYSA-N 0.000 description 5
- WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 125000000392 cycloalkenyl group Chemical group 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical group O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 4
- GXPNBHVGVOPTET-SNVBAGLBSA-N (5-amino-1-benzothiophen-2-yl)-[(3r)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound C=1C2=CC(N)=CC=C2SC=1C(=O)N1CC[C@@H](O)C1 GXPNBHVGVOPTET-SNVBAGLBSA-N 0.000 description 4
- XTSJODSVIJVJPS-UHFFFAOYSA-N 1-phenylbenzimidazole-2,5-diamine Chemical compound NC1=NC2=CC(N)=CC=C2N1C1=CC=CC=C1 XTSJODSVIJVJPS-UHFFFAOYSA-N 0.000 description 4
- FXVPQFWEVKYLME-UHFFFAOYSA-N 2-(bromomethyl)-6-nitroquinoline Chemical compound N1=C(CBr)C=CC2=CC([N+](=O)[O-])=CC=C21 FXVPQFWEVKYLME-UHFFFAOYSA-N 0.000 description 4
- OBFVWUKSMRIYJJ-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine Chemical compound NC1=CC=C2OC(CN(C)C)COC2=C1 OBFVWUKSMRIYJJ-UHFFFAOYSA-N 0.000 description 4
- AYPSHJCKSDNETA-UHFFFAOYSA-N 2-chloro-1h-benzimidazole Chemical compound C1=CC=C2NC(Cl)=NC2=C1 AYPSHJCKSDNETA-UHFFFAOYSA-N 0.000 description 4
- VMRHKCAEQFYIBE-UHFFFAOYSA-N 2-chloro-3-methylbenzimidazol-5-amine Chemical compound C1=C(N)C=C2N(C)C(Cl)=NC2=C1 VMRHKCAEQFYIBE-UHFFFAOYSA-N 0.000 description 4
- TVZZVPWULFTZSN-UHFFFAOYSA-N 3-(2,4-dinitroanilino)propan-1-ol Chemical compound OCCCNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O TVZZVPWULFTZSN-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- CSIWZRJTSWJCKM-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-phenylpiperazin-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCN(CC4)C=4C=CC=CC=4)=NC3=CC=1)C=N2 CSIWZRJTSWJCKM-UHFFFAOYSA-N 0.000 description 4
- RQJWJHHGWVZDIQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[[4-(4-fluorophenyl)piperidin-1-yl]methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(F)=CC=C1C1CCN(CC=2N=C3C=CC(=CC3=CC=2)N2C(C=3SC(=CC=3N=C2)C=2C=CC(Cl)=CC=2)=O)CC1 RQJWJHHGWVZDIQ-UHFFFAOYSA-N 0.000 description 4
- RSCOWRFUSOCDTF-LZYBPNLTSA-N CN(C)\C=N\c1cc(sc1C(O)=O)-c1ccc(Cl)cc1 Chemical compound CN(C)\C=N\c1cc(sc1C(O)=O)-c1ccc(Cl)cc1 RSCOWRFUSOCDTF-LZYBPNLTSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000013058 crude material Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- ORRDHOMWDPJSNL-UHFFFAOYSA-N melanin concentrating hormone Chemical compound N1C(=O)C(C(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(NC(=O)C(N)CC(O)=O)C(C)O)CCSC)CSSCC(C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)C)C(O)=O)NC(=O)C2CCCN2C(=O)C(CCCNC(N)=N)NC(=O)C1CC1=CC=C(O)C=C1 ORRDHOMWDPJSNL-UHFFFAOYSA-N 0.000 description 4
- 102000047659 melanin-concentrating hormone Human genes 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- ZGOFWQZAPZRBSR-UHFFFAOYSA-N (5-amino-1-benzothiophen-2-yl)-(4-phenylpiperazin-1-yl)methanone Chemical compound C=1C2=CC(N)=CC=C2SC=1C(=O)N(CC1)CCN1C1=CC=CC=C1 ZGOFWQZAPZRBSR-UHFFFAOYSA-N 0.000 description 3
- UDFINEKTIZVXIB-UHFFFAOYSA-N (5-amino-1-benzothiophen-2-yl)-(4-phenylpiperidin-1-yl)methanone Chemical compound C=1C2=CC(N)=CC=C2SC=1C(=O)N(CC1)CCC1C1=CC=CC=C1 UDFINEKTIZVXIB-UHFFFAOYSA-N 0.000 description 3
- CZPGEXFVAUMAID-UHFFFAOYSA-N (6-aminonaphthalen-2-yl)methanol Chemical compound C1=C(CO)C=CC2=CC(N)=CC=C21 CZPGEXFVAUMAID-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 3
- PZMKGWRBZNOIPQ-UHFFFAOYSA-N 1h-thieno[3,2-d]pyrimidin-4-one Chemical compound OC1=NC=NC2=C1SC=C2 PZMKGWRBZNOIPQ-UHFFFAOYSA-N 0.000 description 3
- UTTPTRRZAYUUPN-UHFFFAOYSA-N 2-(morpholin-4-ylmethyl)quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN1CCOCC1 UTTPTRRZAYUUPN-UHFFFAOYSA-N 0.000 description 3
- KHLTXMUSFLOCCS-UHFFFAOYSA-N 2-(piperidin-1-ylmethyl)quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN1CCCCC1 KHLTXMUSFLOCCS-UHFFFAOYSA-N 0.000 description 3
- VSRBDXNMFGFCDJ-UHFFFAOYSA-N 2-[(4-phenylpiperidin-1-yl)methyl]-1-benzothiophen-5-amine Chemical compound C=1C2=CC(N)=CC=C2SC=1CN(CC1)CCC1C1=CC=CC=C1 VSRBDXNMFGFCDJ-UHFFFAOYSA-N 0.000 description 3
- SUDHYNMZBNIDBW-UHFFFAOYSA-N 2-[2-(dimethylamino)-5-nitrobenzimidazol-1-yl]ethanol Chemical compound [O-][N+](=O)C1=CC=C2N(CCO)C(N(C)C)=NC2=C1 SUDHYNMZBNIDBW-UHFFFAOYSA-N 0.000 description 3
- YDJMSLGMROYGTC-UHFFFAOYSA-N 2-[2-(dimethylamino)-6-nitrobenzimidazol-1-yl]ethanol Chemical compound C1=C([N+]([O-])=O)C=C2N(CCO)C(N(C)C)=NC2=C1 YDJMSLGMROYGTC-UHFFFAOYSA-N 0.000 description 3
- QIMWOOBHVIUZIP-UHFFFAOYSA-N 2-[[4-(4-fluorophenyl)piperidin-1-yl]methyl]quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN(CC1)CCC1C1=CC=C(F)C=C1 QIMWOOBHVIUZIP-UHFFFAOYSA-N 0.000 description 3
- POULBABPILHZQH-UHFFFAOYSA-N 2-[[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methyl]quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN(CC1)CCC1C1=CC=C(C(F)(F)F)C=C1 POULBABPILHZQH-UHFFFAOYSA-N 0.000 description 3
- QNYFEUMEQHKASR-UHFFFAOYSA-N 2-chloro-1-methyl-5-nitrobenzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N(C)C(Cl)=NC2=C1 QNYFEUMEQHKASR-UHFFFAOYSA-N 0.000 description 3
- PTEJPYNTLJOJBM-UHFFFAOYSA-N 2-chloro-1-methylbenzimidazol-5-amine Chemical compound NC1=CC=C2N(C)C(Cl)=NC2=C1 PTEJPYNTLJOJBM-UHFFFAOYSA-N 0.000 description 3
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 3
- GYUUGQVCEFOBMA-UHFFFAOYSA-N 3-[2-(dimethylamino)-3-methylbenzimidazol-5-yl]-6-(4-nitrophenyl)thieno[3,2-d]pyrimidin-4-one Chemical compound C1=C2N(C)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C([N+]([O-])=O)C=C1 GYUUGQVCEFOBMA-UHFFFAOYSA-N 0.000 description 3
- PBEFYZYHKCFHEK-UHFFFAOYSA-N 4-[(6-nitroquinolin-2-yl)methyl]morpholine Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN1CCOCC1 PBEFYZYHKCFHEK-UHFFFAOYSA-N 0.000 description 3
- DASVYRORIVFNNR-UHFFFAOYSA-N 5-nitro-1-phenylbenzimidazol-2-amine Chemical compound NC1=NC2=CC([N+]([O-])=O)=CC=C2N1C1=CC=CC=C1 DASVYRORIVFNNR-UHFFFAOYSA-N 0.000 description 3
- WWPGTYXGCMWETG-QGZVFWFLSA-N 6-(4-chlorophenyl)-3-[(2r)-2-[(dimethylamino)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C([C@H](OC1=CC=2)CN(C)C)OC1=CC=2N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 WWPGTYXGCMWETG-QGZVFWFLSA-N 0.000 description 3
- LAOLAICCPSJBOW-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(2-pyrrolidin-1-ylethylamino)-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3N=C(NCCN4CCCC4)NC3=CC=1)C=N2 LAOLAICCPSJBOW-UHFFFAOYSA-N 0.000 description 3
- UBGBTGVLKSVQKG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(morpholin-4-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCOCC4)=NC3=CC=1)C=N2 UBGBTGVLKSVQKG-UHFFFAOYSA-N 0.000 description 3
- RAXCDNRFFLXBJM-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC2=NC(CN(C)C)=CC=C2C=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 RAXCDNRFFLXBJM-UHFFFAOYSA-N 0.000 description 3
- PZJPGXPFQBLOHQ-UHFFFAOYSA-N 6-(piperidin-1-ylmethyl)naphthalen-2-amine Chemical compound C1=CC2=CC(N)=CC=C2C=C1CN1CCCCC1 PZJPGXPFQBLOHQ-UHFFFAOYSA-N 0.000 description 3
- NZTPZUIIYNYZKT-UHFFFAOYSA-N 6-aminonaphthalene-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(N)=CC=C21 NZTPZUIIYNYZKT-UHFFFAOYSA-N 0.000 description 3
- UEPWMGSYZCLGTA-UHFFFAOYSA-N 6-nitro-2-(piperidin-1-ylmethyl)quinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN1CCCCC1 UEPWMGSYZCLGTA-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- JARDQBGPGULCLT-BTJKTKAUSA-N C(\C=C/C(=O)O)(=O)O.N1=CNC(C=C1)=O Chemical compound C(\C=C/C(=O)O)(=O)O.N1=CNC(C=C1)=O JARDQBGPGULCLT-BTJKTKAUSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 102400001132 Melanin-concentrating hormone Human genes 0.000 description 3
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- IOADKSJEOBWNKJ-SNVBAGLBSA-N [(3r)-3-hydroxypyrrolidin-1-yl]-(5-nitro-1-benzothiophen-2-yl)methanone Chemical compound C1[C@H](O)CCN1C(=O)C1=CC2=CC([N+]([O-])=O)=CC=C2S1 IOADKSJEOBWNKJ-SNVBAGLBSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- NRNFKRFWZQQDMD-UHFFFAOYSA-M dichloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=C(Cl)Cl NRNFKRFWZQQDMD-UHFFFAOYSA-M 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- MELGGDOYSMRBGA-UHFFFAOYSA-N methyl 3-amino-5-(4-chlorophenyl)thiophene-2-carboxylate Chemical compound NC1=C(C(=O)OC)SC(C=2C=CC(Cl)=CC=2)=C1 MELGGDOYSMRBGA-UHFFFAOYSA-N 0.000 description 3
- NVUFFVPGEHZJFW-UHFFFAOYSA-N methyl 3-amino-5-(4-nitrophenyl)thiophene-2-carboxylate Chemical compound NC1=C(C(=O)OC)SC(C=2C=CC(=CC=2)[N+]([O-])=O)=C1 NVUFFVPGEHZJFW-UHFFFAOYSA-N 0.000 description 3
- ALWFLYMKFZJTBB-UHFFFAOYSA-N methyl 5-(4-chlorophenyl)-3-(dimethylaminomethylideneamino)thiophene-2-carboxylate Chemical compound CN(C)C=NC1=C(C(=O)OC)SC(C=2C=CC(Cl)=CC=2)=C1 ALWFLYMKFZJTBB-UHFFFAOYSA-N 0.000 description 3
- OSVZEJHBIFIMJF-UHFFFAOYSA-N methyl 5-nitro-1-benzothiophene-2-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2SC(C(=O)OC)=CC2=C1 OSVZEJHBIFIMJF-UHFFFAOYSA-N 0.000 description 3
- LPXVPYIHRFOTJZ-UHFFFAOYSA-N methyl 6-aminonaphthalene-2-carboxylate Chemical compound C1=C(N)C=CC2=CC(C(=O)OC)=CC=C21 LPXVPYIHRFOTJZ-UHFFFAOYSA-N 0.000 description 3
- JYQBABBYGMOLTJ-UHFFFAOYSA-N n,n-dimethyl-6-nitro-1-prop-2-enylbenzimidazol-2-amine Chemical compound C1=C([N+]([O-])=O)C=C2N(CC=C)C(N(C)C)=NC2=C1 JYQBABBYGMOLTJ-UHFFFAOYSA-N 0.000 description 3
- SGBUHGQBGANFIV-UHFFFAOYSA-N n-(6-formylnaphthalen-2-yl)-2,2-dimethylpropanamide Chemical compound C1=C(C=O)C=CC2=CC(NC(=O)C(C)(C)C)=CC=C21 SGBUHGQBGANFIV-UHFFFAOYSA-N 0.000 description 3
- GYGYDOOXVKDZCF-UHFFFAOYSA-N n-methyl-2-pyrrolidin-1-ylethanamine Chemical compound CNCCN1CCCC1 GYGYDOOXVKDZCF-UHFFFAOYSA-N 0.000 description 3
- NYEYJFUSHTYTFF-UHFFFAOYSA-N n-methyl-5-nitro-1-phenylbenzimidazol-2-amine Chemical compound CNC1=NC2=CC([N+]([O-])=O)=CC=C2N1C1=CC=CC=C1 NYEYJFUSHTYTFF-UHFFFAOYSA-N 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- CHPRFKYDQRKRRK-ZCFIWIBFSA-N (2r)-2-(methoxymethyl)pyrrolidine Chemical compound COC[C@H]1CCCN1 CHPRFKYDQRKRRK-ZCFIWIBFSA-N 0.000 description 2
- XCKDLEDCGWEDOQ-SECBINFHSA-N (2r)-2-[[2-(methoxymethoxy)-5-nitrophenoxy]methyl]oxirane Chemical compound COCOC1=CC=C([N+]([O-])=O)C=C1OC[C@@H]1OC1 XCKDLEDCGWEDOQ-SECBINFHSA-N 0.000 description 2
- JHHZLHWJQPUNKB-BYPYZUCNSA-N (3s)-pyrrolidin-3-ol Chemical compound O[C@H]1CCNC1 JHHZLHWJQPUNKB-BYPYZUCNSA-N 0.000 description 2
- CWRRKRGYQNLVBU-UHFFFAOYSA-N (5-amino-1-benzothiophen-2-yl)-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC2=CC(N)=CC=C2S1 CWRRKRGYQNLVBU-UHFFFAOYSA-N 0.000 description 2
- FTRRDCFNKJMQRS-UHFFFAOYSA-N (5-nitro-1-benzothiophen-2-yl)-(4-phenylpiperazin-1-yl)methanone Chemical compound C=1C2=CC([N+](=O)[O-])=CC=C2SC=1C(=O)N(CC1)CCN1C1=CC=CC=C1 FTRRDCFNKJMQRS-UHFFFAOYSA-N 0.000 description 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 2
- CTKINSOISVBQLD-GSVOUGTGSA-N (R)-Glycidol Chemical compound OC[C@@H]1CO1 CTKINSOISVBQLD-GSVOUGTGSA-N 0.000 description 2
- PWJDADFQYZTUAQ-UITAMQMPSA-N (z)-3-chloro-3-(4-nitrophenyl)prop-2-enenitrile Chemical compound [O-][N+](=O)C1=CC=C(C(\Cl)=C\C#N)C=C1 PWJDADFQYZTUAQ-UITAMQMPSA-N 0.000 description 2
- NRSHDCXOQUDIEI-UHFFFAOYSA-N 1-(3-chloropropyl)-n,n-dimethyl-5-nitrobenzimidazol-2-amine Chemical compound [O-][N+](=O)C1=CC=C2N(CCCCl)C(N(C)C)=NC2=C1 NRSHDCXOQUDIEI-UHFFFAOYSA-N 0.000 description 2
- PFSAEUUNXRUXMJ-UHFFFAOYSA-N 1-(chloromethyl)-5-nitrobenzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N(CCl)C=NC2=C1 PFSAEUUNXRUXMJ-UHFFFAOYSA-N 0.000 description 2
- GEBIDLYXGZLTOJ-UHFFFAOYSA-N 1-[(6-aminonaphthalen-2-yl)methyl]piperidin-4-ol Chemical compound C1=CC2=CC(N)=CC=C2C=C1CN1CCC(O)CC1 GEBIDLYXGZLTOJ-UHFFFAOYSA-N 0.000 description 2
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N 1-propanol Substances CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical compound C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 description 2
- RASBDBMQTZKMAD-UHFFFAOYSA-N 2-(2-pyrrolidin-1-ylethyl)-1,3-dihydrobenzimidazole-2,5-diamine Chemical compound N1C2=CC(N)=CC=C2NC1(N)CCN1CCCC1 RASBDBMQTZKMAD-UHFFFAOYSA-N 0.000 description 2
- HRXMMARNIZKHLR-UHFFFAOYSA-N 2-(methoxymethoxy)-5-nitrophenol Chemical compound COCOC1=CC=C([N+]([O-])=O)C=C1O HRXMMARNIZKHLR-UHFFFAOYSA-N 0.000 description 2
- FSZCVSHQVWJBGB-UHFFFAOYSA-N 2-(morpholin-4-ylmethyl)-1-benzothiophen-5-amine Chemical compound C=1C2=CC(N)=CC=C2SC=1CN1CCOCC1 FSZCVSHQVWJBGB-UHFFFAOYSA-N 0.000 description 2
- VJKXQVIKIJCJQZ-UHFFFAOYSA-N 2-(pyrrolidin-1-ylmethyl)quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN1CCCC1 VJKXQVIKIJCJQZ-UHFFFAOYSA-N 0.000 description 2
- UOILWZAXTQTHNV-UHFFFAOYSA-N 2-N,2-dimethyl-1,3-dihydrobenzimidazole-2,5-diamine Chemical compound CC1(NC2=C(N1)C=C(C=C2)N)NC UOILWZAXTQTHNV-UHFFFAOYSA-N 0.000 description 2
- ALSKYUJVXULHBQ-UHFFFAOYSA-N 2-[(4-methylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine Chemical compound C1CN(C)CCN1CC1=CC2=CC(N)=CC=C2S1 ALSKYUJVXULHBQ-UHFFFAOYSA-N 0.000 description 2
- GMJZGJFAMURIMD-UHFFFAOYSA-N 2-[(4-methylpiperazin-1-yl)methyl]quinolin-6-amine Chemical compound C1CN(C)CCN1CC1=CC=C(C=C(N)C=C2)C2=N1 GMJZGJFAMURIMD-UHFFFAOYSA-N 0.000 description 2
- WSZQNEFKZKGHJD-UHFFFAOYSA-N 2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine Chemical compound C=1C2=CC(N)=CC=C2SC=1CN(CC1)CCN1C1=CC=CC=C1 WSZQNEFKZKGHJD-UHFFFAOYSA-N 0.000 description 2
- LANVKIOYLOBIJU-UHFFFAOYSA-N 2-[(4-phenylpiperazin-1-yl)methyl]quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN(CC1)CCN1C1=CC=CC=C1 LANVKIOYLOBIJU-UHFFFAOYSA-N 0.000 description 2
- NSWIQZJMXNVPAF-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-1-benzothiophen-5-amine Chemical compound NC1=CC=C2SC(CN(C)C)=CC2=C1 NSWIQZJMXNVPAF-UHFFFAOYSA-N 0.000 description 2
- AALAFRCTXXQRKK-UHFFFAOYSA-N 2-[[4-(4-fluorophenyl)piperidin-1-yl]methyl]-6-nitroquinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN(CC1)CCC1C1=CC=C(F)C=C1 AALAFRCTXXQRKK-UHFFFAOYSA-N 0.000 description 2
- JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 2
- BAAUCXCLMDAZEL-UHFFFAOYSA-N 2-bromo-5-nitroaniline Chemical compound NC1=CC([N+]([O-])=O)=CC=C1Br BAAUCXCLMDAZEL-UHFFFAOYSA-N 0.000 description 2
- ILYJVWRIZRFLCK-UHFFFAOYSA-N 2-chloro-1-methylbenzimidazole dimethyl sulfate Chemical compound COS(=O)(=O)OC.ClC1=NC2=C(N1C)C=CC=C2 ILYJVWRIZRFLCK-UHFFFAOYSA-N 0.000 description 2
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 2
- DXDPHHQJZWWAEH-UHFFFAOYSA-N 2-methyl-6-nitroquinoline Chemical compound C1=C([N+]([O-])=O)C=CC2=NC(C)=CC=C21 DXDPHHQJZWWAEH-UHFFFAOYSA-N 0.000 description 2
- OEWXPUJPUSCQMA-UHFFFAOYSA-N 3-(2-amino-1-phenylbenzimidazol-5-yl)-6-(4-chlorophenyl)thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NC1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1C1=CC=CC=C1 OEWXPUJPUSCQMA-UHFFFAOYSA-N 0.000 description 2
- OMKRVKUNBKZZRJ-UHFFFAOYSA-N 3-(2-amino-4-nitroanilino)propan-1-ol Chemical compound NC1=CC([N+]([O-])=O)=CC=C1NCCCO OMKRVKUNBKZZRJ-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- MTPKKZOKDAJSHL-UHFFFAOYSA-N 3-[2-[(dimethylamino)methyl]quinolin-6-yl]-7-(4-fluorophenyl)quinazolin-4-one Chemical compound C1=CC2=NC(CN(C)C)=CC=C2C=C1N(C(C1=CC=2)=O)C=NC1=CC=2C1=CC=C(F)C=C1 MTPKKZOKDAJSHL-UHFFFAOYSA-N 0.000 description 2
- IFNLHIRHJNDMBM-UHFFFAOYSA-N 3h-benzimidazole-2,5-diamine Chemical group C1=C(N)C=C2NC(N)=NC2=C1 IFNLHIRHJNDMBM-UHFFFAOYSA-N 0.000 description 2
- AFYALJSDFPSAAZ-UHFFFAOYSA-N 4-(4-fluorophenyl)piperidine Chemical compound C1=CC(F)=CC=C1C1CCNCC1 AFYALJSDFPSAAZ-UHFFFAOYSA-N 0.000 description 2
- WNWVKZTYMQWFHE-UHFFFAOYSA-N 4-ethylmorpholine Chemical group [CH2]CN1CCOCC1 WNWVKZTYMQWFHE-UHFFFAOYSA-N 0.000 description 2
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 2
- PQMGRVXQAFKVMO-UHFFFAOYSA-N 4-nitro-1-n-phenylbenzene-1,2-diamine Chemical compound NC1=CC([N+]([O-])=O)=CC=C1NC1=CC=CC=C1 PQMGRVXQAFKVMO-UHFFFAOYSA-N 0.000 description 2
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 2
- GTLXJJFIRIDEOP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(2,4-dihydro-1h-imidazo[1,2-a]benzimidazol-6-yl)thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3N=C4NCCN4C3=CC=1)C=N2 GTLXJJFIRIDEOP-UHFFFAOYSA-N 0.000 description 2
- CDUDDFAXMJGYHS-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(2-morpholin-4-yl-3h-benzimidazol-5-yl)thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3NC(=NC3=CC=1)N1CCOCC1)C=N2 CDUDDFAXMJGYHS-UHFFFAOYSA-N 0.000 description 2
- WWPGTYXGCMWETG-KRWDZBQOSA-N 6-(4-chlorophenyl)-3-[(2s)-2-[(dimethylamino)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C([C@@H](OC1=CC=2)CN(C)C)OC1=CC=2N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 WWPGTYXGCMWETG-KRWDZBQOSA-N 0.000 description 2
- CRIWIJMCJCCDJP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[1-(3-methoxypropyl)-2-(methylamino)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCCOC)C(NC)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 CRIWIJMCJCCDJP-UHFFFAOYSA-N 0.000 description 2
- PFFMJYGFJRSMTK-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(2-morpholin-4-ylethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound CN(C)C1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCN1CCOCC1 PFFMJYGFJRSMTK-UHFFFAOYSA-N 0.000 description 2
- MRJAZYINYQKBHU-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(3-hydroxypropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCCO)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 MRJAZYINYQKBHU-UHFFFAOYSA-N 0.000 description 2
- KLTKJEAQAVJCNO-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-propylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCC)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 KLTKJEAQAVJCNO-UHFFFAOYSA-N 0.000 description 2
- KIMNYQJWTYRSKP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2NC(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 KIMNYQJWTYRSKP-UHFFFAOYSA-N 0.000 description 2
- SIMIMDQKZHJQIP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(methylamino)-1-(2-morpholin-4-ylethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CNC1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCN1CCOCC1 SIMIMDQKZHJQIP-UHFFFAOYSA-N 0.000 description 2
- YIBPPXKCYWGKQV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(morpholin-4-ylmethyl)-3,4-dihydro-2h-1,4-benzoxazin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3NCC(CN4CCOCC4)OC3=CC=1)C=N2 YIBPPXKCYWGKQV-UHFFFAOYSA-N 0.000 description 2
- UUZGQDHCPMCNHE-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(piperidin-1-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCCC4)=NC3=CC=1)C=N2 UUZGQDHCPMCNHE-UHFFFAOYSA-N 0.000 description 2
- QOKPEQZKMJABFG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(pyrrolidin-1-ylmethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCC4)=NC3=CC=1)C=N2 QOKPEQZKMJABFG-UHFFFAOYSA-N 0.000 description 2
- YLNMKOAPZKIZAU-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-methylpiperazin-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=N1 YLNMKOAPZKIZAU-UHFFFAOYSA-N 0.000 description 2
- ODMRZHCWTPHENJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-phenylpiperidin-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCC(CC4)C=4C=CC=CC=4)=NC3=CC=1)C=N2 ODMRZHCWTPHENJ-UHFFFAOYSA-N 0.000 description 2
- WWPGTYXGCMWETG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2OC(CN(C)C)COC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 WWPGTYXGCMWETG-UHFFFAOYSA-N 0.000 description 2
- ZDFHQJRHOKOKEF-LJQANCHMSA-N 6-(4-chlorophenyl)-3-[2-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1[C@H](O)CCN1CC1=CC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2S1 ZDFHQJRHOKOKEF-LJQANCHMSA-N 0.000 description 2
- SYSAVTQUDIIZMN-OAQYLSRUSA-N 6-(4-chlorophenyl)-3-[2-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1[C@H](O)CCN1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=N1 SYSAVTQUDIIZMN-OAQYLSRUSA-N 0.000 description 2
- GLHXGJYSHGLSID-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C1CCN(CC=2N=C3C=CC(=CC3=CC=2)N2C(C=3SC(=CC=3N=C2)C=2C=CC(Cl)=CC=2)=O)CC1 GLHXGJYSHGLSID-UHFFFAOYSA-N 0.000 description 2
- YMXJYBASNOPRDP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[3-methyl-2-[methyl(2-pyrrolidin-1-ylethyl)amino]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N=1C2=CC=C(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C=C2N(C)C=1N(C)CCN1CCCC1 YMXJYBASNOPRDP-UHFFFAOYSA-N 0.000 description 2
- FJPBPFUKHDZYIJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-(piperidin-1-ylmethyl)naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCCC4)=CC3=CC=1)C=N2 FJPBPFUKHDZYIJ-UHFFFAOYSA-N 0.000 description 2
- GZTRTESDPOCGER-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-(pyrrolidine-1-carbonyl)naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(=CC3=CC=1)C(=O)N1CCCC1)C=N2 GZTRTESDPOCGER-UHFFFAOYSA-N 0.000 description 2
- LYRLHBRLOOFCON-UHFFFAOYSA-N 6-nitro-2-[(4-phenylpiperazin-1-yl)methyl]quinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN(CC1)CCN1C1=CC=CC=C1 LYRLHBRLOOFCON-UHFFFAOYSA-N 0.000 description 2
- OLVIMDBYIORTQQ-UHFFFAOYSA-N 6-nitro-n-(2-pyrrolidin-1-ylethyl)-1h-benzimidazol-2-amine Chemical compound N1C2=CC([N+](=O)[O-])=CC=C2N=C1NCCN1CCCC1 OLVIMDBYIORTQQ-UHFFFAOYSA-N 0.000 description 2
- BOUDHYSDNNTOQD-UHFFFAOYSA-N 6-nitroquinoline-2-carbaldehyde Chemical compound N1=C(C=O)C=CC2=CC([N+](=O)[O-])=CC=C21 BOUDHYSDNNTOQD-UHFFFAOYSA-N 0.000 description 2
- ITUDRVWBSXRWPG-UHFFFAOYSA-N 7-(4-fluorophenyl)-3-[2-(pyrrolidin-1-ylmethyl)quinolin-6-yl]quinazolin-4-one Chemical compound C1=CC(F)=CC=C1C1=CC=C2C(=O)N(C=3C=C4C=CC(CN5CCCC5)=NC4=CC=3)C=NC2=C1 ITUDRVWBSXRWPG-UHFFFAOYSA-N 0.000 description 2
- PORJLQKWTXZDBE-UHFFFAOYSA-N 7-chloro-3-[2-[(dimethylamino)methyl]quinolin-6-yl]quinazolin-4-one Chemical compound C1=NC2=CC(Cl)=CC=C2C(=O)N1C1=CC2=CC=C(CN(C)C)N=C2C=C1 PORJLQKWTXZDBE-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- GLQKSOCKLXWYJP-UHFFFAOYSA-N N,N-dimethyl-1-[3-(methylamino)propyl]-5-nitrobenzimidazol-2-amine Chemical compound CNCCCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1N(C)C GLQKSOCKLXWYJP-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- HDUHGHUBQYHGRV-UHFFFAOYSA-N [N+](=O)([O-])CC1=CC=C(C=C1)S(=O)(=O)O.C1(CCCCC1)N=C=NCCN1CCOCC1 Chemical compound [N+](=O)([O-])CC1=CC=C(C=C1)S(=O)(=O)O.C1(CCCCC1)N=C=NCCN1CCOCC1 HDUHGHUBQYHGRV-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229910000086 alane Inorganic materials 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- GUYPRVGNUBESTL-UHFFFAOYSA-N n,n-dimethyl-5-nitro-1-prop-2-enylbenzimidazol-2-amine Chemical compound [O-][N+](=O)C1=CC=C2N(CC=C)C(N(C)C)=NC2=C1 GUYPRVGNUBESTL-UHFFFAOYSA-N 0.000 description 2
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical group NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 2
- RMUBVWYKEAVVEH-UHFFFAOYSA-N n-methyl-1-(6-nitroquinolin-2-yl)methanamine Chemical compound C1=C([N+]([O-])=O)C=CC2=NC(CNC)=CC=C21 RMUBVWYKEAVVEH-UHFFFAOYSA-N 0.000 description 2
- 150000002829 nitrogen Chemical class 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- CYKBEPMIQVVVMZ-UHFFFAOYSA-N (2,3-ditert-butyl-6-phenylphenyl)phosphane Chemical group PC1=C(C(C)(C)C)C(C(C)(C)C)=CC=C1C1=CC=CC=C1 CYKBEPMIQVVVMZ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-NRXMZTRTSA-N (2r,3r,4r,5s)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-NRXMZTRTSA-N 0.000 description 1
- XCKDLEDCGWEDOQ-VIFPVBQESA-N (2s)-2-[[2-(methoxymethoxy)-5-nitrophenoxy]methyl]oxirane Chemical compound COCOC1=CC=C([N+]([O-])=O)C=C1OC[C@H]1OC1 XCKDLEDCGWEDOQ-VIFPVBQESA-N 0.000 description 1
- MWEWNIJJFJIPEV-CYBMUJFWSA-N (3r)-1-[(6-aminoquinolin-2-yl)methyl]pyrrolidin-3-ol Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN1CC[C@@H](O)C1 MWEWNIJJFJIPEV-CYBMUJFWSA-N 0.000 description 1
- IHKZRAKSZJHBKZ-CYBMUJFWSA-N (3r)-1-[(6-nitroquinolin-2-yl)methyl]pyrrolidin-3-ol Chemical compound C1[C@H](O)CCN1CC1=CC=C(C=C(C=C2)[N+]([O-])=O)C2=N1 IHKZRAKSZJHBKZ-CYBMUJFWSA-N 0.000 description 1
- CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
- SJZMIZIVYIOMIW-UHFFFAOYSA-N (4-methylcyclohexen-1-yl)boronic acid Chemical compound CC1CCC(B(O)O)=CC1 SJZMIZIVYIOMIW-UHFFFAOYSA-N 0.000 description 1
- TWTSSQFQXROMDD-UHFFFAOYSA-N (4-methylpiperazin-1-yl)-(5-nitro-1-benzothiophen-2-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC2=CC([N+]([O-])=O)=CC=C2S1 TWTSSQFQXROMDD-UHFFFAOYSA-N 0.000 description 1
- QLLFUMWZSKLVAI-UHFFFAOYSA-N (5-amino-1-benzothiophen-2-yl)-morpholin-4-ylmethanone Chemical compound C=1C2=CC(N)=CC=C2SC=1C(=O)N1CCOCC1 QLLFUMWZSKLVAI-UHFFFAOYSA-N 0.000 description 1
- KKQLJJHKFRREOT-UHFFFAOYSA-N (5-nitro-1-benzothiophen-2-yl)-(4-phenylpiperidin-1-yl)methanone Chemical compound C=1C2=CC([N+](=O)[O-])=CC=C2SC=1C(=O)N(CC1)CCC1C1=CC=CC=C1 KKQLJJHKFRREOT-UHFFFAOYSA-N 0.000 description 1
- XWMQCYNSLNSYDQ-UHFFFAOYSA-N (6-aminonaphthalen-2-yl)-pyrrolidin-1-ylmethanone Chemical compound C1=CC2=CC(N)=CC=C2C=C1C(=O)N1CCCC1 XWMQCYNSLNSYDQ-UHFFFAOYSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 description 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 1
- CTKINSOISVBQLD-VKHMYHEASA-N (S)-Glycidol Chemical compound OC[C@H]1CO1 CTKINSOISVBQLD-VKHMYHEASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- HWZHAJZROMVUPX-BTJKTKAUSA-N (z)-but-2-enedioic acid;6-(4-chlorophenyl)-3-[6-(pyrrolidin-1-ylmethyl)naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound OC(=O)\C=C/C(O)=O.C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CCCC4)=CC3=CC=1)C=N2 HWZHAJZROMVUPX-BTJKTKAUSA-N 0.000 description 1
- UDSJBTQHEYUGMF-BTJKTKAUSA-N (z)-but-2-enedioic acid;6-(4-methylphenyl)-3-[2-(pyrrolidin-1-ylmethyl)-1-benzofuran-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound OC(=O)\C=C/C(O)=O.C1=CC(C)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=C(CN4CCCC4)OC3=CC=1)C=N2 UDSJBTQHEYUGMF-BTJKTKAUSA-N 0.000 description 1
- BFUROHQDYIQDPX-UHFFFAOYSA-N 1,2-dichloroethane;n-methylmethanamine Chemical compound CNC.ClCCCl BFUROHQDYIQDPX-UHFFFAOYSA-N 0.000 description 1
- KUEHNDLYGQZCDU-UHFFFAOYSA-N 1,4-dimethyl-5-nitrobenzimidazol-2-amine Chemical compound CC1=C([N+]([O-])=O)C=CC2=C1N=C(N)N2C KUEHNDLYGQZCDU-UHFFFAOYSA-N 0.000 description 1
- FIYRKJRJAILHQJ-UHFFFAOYSA-N 1-(3-methoxypropyl)-n,n-dimethyl-5-nitrobenzimidazol-2-amine Chemical compound [O-][N+](=O)C1=CC=C2N(CCCOC)C(N(C)C)=NC2=C1 FIYRKJRJAILHQJ-UHFFFAOYSA-N 0.000 description 1
- GIWDNSYJBPPKRQ-UHFFFAOYSA-N 1-(3-methoxypropyl)-n-methyl-5-nitrobenzimidazol-2-amine Chemical compound [O-][N+](=O)C1=CC=C2N(CCCOC)C(NC)=NC2=C1 GIWDNSYJBPPKRQ-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OLPGSCGBZNSRLT-UHFFFAOYSA-N 1-[(5-nitro-1-benzofuran-2-yl)methyl]pyrrolidine Chemical compound C=1C2=CC([N+](=O)[O-])=CC=C2OC=1CN1CCCC1 OLPGSCGBZNSRLT-UHFFFAOYSA-N 0.000 description 1
- ZUPYTANKWDPRDP-UHFFFAOYSA-N 1-benzothiophen-5-amine Chemical compound NC1=CC=C2SC=CC2=C1 ZUPYTANKWDPRDP-UHFFFAOYSA-N 0.000 description 1
- PRIGFEJKMMRJSF-UHFFFAOYSA-M 1-fluoro-2,4,6-trimethylpyridin-1-ium;trifluoromethanesulfonate Chemical group [O-]S(=O)(=O)C(F)(F)F.CC1=CC(C)=[N+](F)C(C)=C1 PRIGFEJKMMRJSF-UHFFFAOYSA-M 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CKQWIXDWKBDYDL-UHFFFAOYSA-N 1-methyl-2-pyrrolidin-1-ylbenzimidazol-5-amine Chemical compound N=1C2=CC(N)=CC=C2N(C)C=1N1CCCC1 CKQWIXDWKBDYDL-UHFFFAOYSA-N 0.000 description 1
- FGYADSCZTQOAFK-UHFFFAOYSA-N 1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C=NC2=C1 FGYADSCZTQOAFK-UHFFFAOYSA-N 0.000 description 1
- MNIKERWISBANET-UHFFFAOYSA-N 1-n-methyl-4-nitrobenzene-1,2-diamine Chemical compound CNC1=CC=C([N+]([O-])=O)C=C1N MNIKERWISBANET-UHFFFAOYSA-N 0.000 description 1
- IHSYLRPDGCJGNV-UHFFFAOYSA-N 1-prop-2-enylbenzimidazol-2-amine Chemical compound C1=CC=C2N(CC=C)C(N)=NC2=C1 IHSYLRPDGCJGNV-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- RHTVQEPJVKUMPI-UHFFFAOYSA-N 2,4-dinitro-n-phenylaniline Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC=C1NC1=CC=CC=C1 RHTVQEPJVKUMPI-UHFFFAOYSA-N 0.000 description 1
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
- SPMLMLQATWNZEE-UHFFFAOYSA-N 2-(chloromethyl)-1h-benzimidazole Chemical compound C1=CC=C2NC(CCl)=NC2=C1 SPMLMLQATWNZEE-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- WYSMELMOWHPGFH-UHFFFAOYSA-N 2-[(4-methylpiperazin-1-yl)methyl]-6-nitroquinoline Chemical compound C1CN(C)CCN1CC1=CC=C(C=C(C=C2)[N+]([O-])=O)C2=N1 WYSMELMOWHPGFH-UHFFFAOYSA-N 0.000 description 1
- FKDWIFDBEKDYPT-UHFFFAOYSA-N 2-[(4-phenylpiperidin-1-yl)methyl]quinolin-6-amine Chemical compound C1=CC2=CC(N)=CC=C2N=C1CN(CC1)CCC1C1=CC=CC=C1 FKDWIFDBEKDYPT-UHFFFAOYSA-N 0.000 description 1
- MPBIOJIYQNKPFH-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-3h-benzimidazol-5-amine Chemical compound C1=C(N)C=C2NC(CN(C)C)=NC2=C1 MPBIOJIYQNKPFH-UHFFFAOYSA-N 0.000 description 1
- YSQPDQWTQJTPQT-UHFFFAOYSA-N 2-[(dimethylamino)methyl]quinolin-6-amine N,N-dimethyl-1-(6-nitroquinolin-2-yl)methanamine Chemical compound CN(CC1=NC2=CC=C(C=C2C=C1)[N+](=O)[O-])C.CN(C)CC1=NC2=CC=C(C=C2C=C1)N YSQPDQWTQJTPQT-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical group OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- UXZYKSFMGDWHGJ-UHFFFAOYSA-N 2-chloro-1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C(Cl)=NC2=C1 UXZYKSFMGDWHGJ-UHFFFAOYSA-N 0.000 description 1
- QLHVJBXAQWPEDI-UHFFFAOYSA-N 2-chloro-3,5-dinitropyridine Chemical compound [O-][N+](=O)C1=CN=C(Cl)C([N+]([O-])=O)=C1 QLHVJBXAQWPEDI-UHFFFAOYSA-N 0.000 description 1
- HCPPGSITODINMJ-UHFFFAOYSA-N 2-chloro-3h-benzimidazol-5-amine Chemical compound NC1=CC=C2N=C(Cl)NC2=C1 HCPPGSITODINMJ-UHFFFAOYSA-N 0.000 description 1
- VFVHWCKUHAEDMY-UHFFFAOYSA-N 2-chloro-5-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(C=O)=C1 VFVHWCKUHAEDMY-UHFFFAOYSA-N 0.000 description 1
- GWSMACGSFHRVFA-UHFFFAOYSA-N 2-chloro-6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=C(Cl)NC2=C1 GWSMACGSFHRVFA-UHFFFAOYSA-N 0.000 description 1
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- TYJFYUVDUUACKX-UHFFFAOYSA-N 2-methylquinolin-6-amine Chemical compound C1=C(N)C=CC2=NC(C)=CC=C21 TYJFYUVDUUACKX-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- NKAPXWIFLZNFAE-UHFFFAOYSA-N 2-piperidin-1-yl-3h-benzimidazol-5-amine Chemical compound N1C2=CC(N)=CC=C2N=C1N1CCCCC1 NKAPXWIFLZNFAE-UHFFFAOYSA-N 0.000 description 1
- NEQSASHFNZFAJU-UHFFFAOYSA-N 3-(2-amino-3h-benzimidazol-5-yl)-6-(4-chlorophenyl)thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2NC(N)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 NEQSASHFNZFAJU-UHFFFAOYSA-N 0.000 description 1
- QYVBGTDPRZABMI-UHFFFAOYSA-N 3-(2-methyl-5-nitrobenzimidazol-1-yl)propan-1-ol Chemical compound [O-][N+](=O)C1=CC=C2N(CCCO)C(C)=NC2=C1 QYVBGTDPRZABMI-UHFFFAOYSA-N 0.000 description 1
- HRPNJTNRIGPSJR-UHFFFAOYSA-N 3-[(5-amino-1-methylbenzimidazol-2-yl)-methylamino]propan-1-ol Chemical compound NC1=CC=C2N(C)C(N(CCCO)C)=NC2=C1 HRPNJTNRIGPSJR-UHFFFAOYSA-N 0.000 description 1
- YJZHDKIPGFHHAX-UHFFFAOYSA-N 3-[2-(dimethylamino)-3-methylbenzimidazol-5-yl]-6-(4-fluorophenyl)thieno[3,2-d]pyrimidin-4-one Chemical compound C1=C2N(C)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(F)C=C1 YJZHDKIPGFHHAX-UHFFFAOYSA-N 0.000 description 1
- ZZZACMKPPJXNCV-UHFFFAOYSA-N 3-[2-(dimethylamino)ethyl]-2-N,2-N-dimethylbenzimidazole-2,5-diamine Chemical compound CN(C)CCN1C2=C(C=CC(=C2)N)N=C1N(C)C ZZZACMKPPJXNCV-UHFFFAOYSA-N 0.000 description 1
- HTTXGCKIKMLVMR-UHFFFAOYSA-N 3-amino-5-(4-chlorophenyl)thiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N)C=C1C1=CC=C(Cl)C=C1 HTTXGCKIKMLVMR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PSUXTZLDBVEZTD-UHFFFAOYSA-N 3-bromopropoxymethylbenzene Chemical compound BrCCCOCC1=CC=CC=C1 PSUXTZLDBVEZTD-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- FAXDZWQIWUSWJH-UHFFFAOYSA-N 3-methoxypropan-1-amine Chemical compound COCCCN FAXDZWQIWUSWJH-UHFFFAOYSA-N 0.000 description 1
- VPBWZBGZWHDNKL-UHFFFAOYSA-N 3-pyrrolidin-1-ylpropan-1-amine Chemical compound NCCCN1CCCC1 VPBWZBGZWHDNKL-UHFFFAOYSA-N 0.000 description 1
- WFRXSXUDWCVSPI-UHFFFAOYSA-N 3h-benzimidazol-5-amine Chemical compound NC1=CC=C2NC=NC2=C1 WFRXSXUDWCVSPI-UHFFFAOYSA-N 0.000 description 1
- MMJYSVRCFSCVCI-UHFFFAOYSA-N 4-chloro-2-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC(Cl)=CC=C1C(Cl)=O MMJYSVRCFSCVCI-UHFFFAOYSA-N 0.000 description 1
- AOEUGQNYIVSOFK-UHFFFAOYSA-N 4-chloro-n-(2-methylquinolin-6-yl)-2-nitrobenzamide Chemical compound C1=CC2=NC(C)=CC=C2C=C1NC(=O)C1=CC=C(Cl)C=C1[N+]([O-])=O AOEUGQNYIVSOFK-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- YQYGPGKTNQNXMH-UHFFFAOYSA-N 4-nitroacetophenone Chemical compound CC(=O)C1=CC=C([N+]([O-])=O)C=C1 YQYGPGKTNQNXMH-UHFFFAOYSA-N 0.000 description 1
- XJNPNXSISMKQEX-UHFFFAOYSA-N 4-nitrocatechol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1O XJNPNXSISMKQEX-UHFFFAOYSA-N 0.000 description 1
- YOFXYDVYMHOXSY-UHFFFAOYSA-N 5-(4-fluorophenyl)thiophene-2-carboxylic acid Chemical group S1C(C(=O)O)=CC=C1C1=CC=C(F)C=C1 YOFXYDVYMHOXSY-UHFFFAOYSA-N 0.000 description 1
- GJEWXBDQJPCQOR-UHFFFAOYSA-N 5-amino-n,n-dimethyl-1-benzothiophene-2-carboxamide Chemical compound NC1=CC=C2SC(C(=O)N(C)C)=CC2=C1 GJEWXBDQJPCQOR-UHFFFAOYSA-N 0.000 description 1
- LXJRAFNQLZHUFK-UHFFFAOYSA-N 5-nitro-1-benzofuran-2-carboxylic acid (5-nitro-1-benzofuran-2-yl)-pyrrolidin-1-ylmethanone Chemical compound [N+](=O)([O-])C=1C=CC2=C(C=C(O2)C(=O)O)C1.[N+](=O)([O-])C=1C=CC2=C(C=C(O2)C(=O)N2CCCC2)C1 LXJRAFNQLZHUFK-UHFFFAOYSA-N 0.000 description 1
- HMRICAMPAWIOME-UHFFFAOYSA-N 6-(2-chlorophenyl)-3-[2-(dimethylamino)-3-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=C2N(C)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=CC=C1Cl HMRICAMPAWIOME-UHFFFAOYSA-N 0.000 description 1
- NAVULPDUKBWACV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(1-methyl-2-pyrrolidin-1-ylbenzimidazol-5-yl)thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2N(C)C(N3CCCC3)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 NAVULPDUKBWACV-UHFFFAOYSA-N 0.000 description 1
- KTMIKMWENVUIBU-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(2-piperidin-1-yl-3H-benzimidazol-5-yl)thieno[3,2-d]pyrimidin-4-one 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.Clc1ccc(cc1)-c1cc2ncn(-c3ccc4[nH]c(nc4c3)N3CCCCC3)c(=O)c2s1 KTMIKMWENVUIBU-UHFFFAOYSA-N 0.000 description 1
- JLCHTHHHWQIEOV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(3-methyl-1,2-dihydroimidazo[1,2-a]benzimidazol-6-yl)thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN1CCN(C2=CC=3)C1=NC2=CC=3N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 JLCHTHHHWQIEOV-UHFFFAOYSA-N 0.000 description 1
- HZSQILVFLHRBJH-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-(3-methyl-2-pyrrolidin-1-ylbenzimidazol-5-yl)thieno[3,2-d]pyrimidin-4-one Chemical compound C1=C2N(C)C(N3CCCC3)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 HZSQILVFLHRBJH-UHFFFAOYSA-N 0.000 description 1
- LXZGGZWBBGPVIA-LJQANCHMSA-N 6-(4-chlorophenyl)-3-[(2r)-2-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3OC[C@@H](CN4CCCC4)OC3=CC=1)C=N2 LXZGGZWBBGPVIA-LJQANCHMSA-N 0.000 description 1
- LXZGGZWBBGPVIA-IBGZPJMESA-N 6-(4-chlorophenyl)-3-[(2s)-2-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3OC[C@H](CN4CCCC4)OC3=CC=1)C=N2 LXZGGZWBBGPVIA-IBGZPJMESA-N 0.000 description 1
- YBYHXBZAMVTRQP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3N=CN(CCN4CCCC4)C3=CC=1)C=N2 YBYHXBZAMVTRQP-UHFFFAOYSA-N 0.000 description 1
- PRQIFFVYVSMFGF-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[1-[3-[ethyl(methyl)amino]propyl]-2-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCN(C)CCCn1c(C)nc2cc(ccc12)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1 PRQIFFVYVSMFGF-UHFFFAOYSA-N 0.000 description 1
- WOYUDOBNZAHHDB-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[1-methyl-2-(pyrrolidin-1-ylmethyl)indol-5-yl]thieno[3,2-d]pyrimidin-4-one;hydrochloride Chemical compound Cl.C=1C2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N(C)C=1CN1CCCC1 WOYUDOBNZAHHDB-UHFFFAOYSA-N 0.000 description 1
- MTBRZOOMWMRLBS-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[1-methyl-2-[methyl(2-pyrrolidin-1-ylethyl)amino]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N=1C2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N(C)C=1N(C)CCN1CCCC1 MTBRZOOMWMRLBS-UHFFFAOYSA-N 0.000 description 1
- VQPYAILPPRIWGF-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(2-methoxyethylamino)-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2NC(NCCOC)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 VQPYAILPPRIWGF-UHFFFAOYSA-N 0.000 description 1
- RHHYVOUXHADFMO-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(4-methylpiperazin-1-yl)-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1C1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1 RHHYVOUXHADFMO-UHFFFAOYSA-N 0.000 description 1
- NFJNDCDJCMFMRC-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(2-hydroxyethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2N(CCO)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 NFJNDCDJCMFMRC-UHFFFAOYSA-N 0.000 description 1
- RJQCPVSBSPGCCT-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(3-morpholin-4-ylpropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C)C1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCCN1CCOCC1 RJQCPVSBSPGCCT-UHFFFAOYSA-N 0.000 description 1
- OHFUTUGZUWQNFS-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(3-piperidin-1-ylpropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C)C1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCCN1CCCCC1 OHFUTUGZUWQNFS-UHFFFAOYSA-N 0.000 description 1
- XHKJVYYAWRNGMP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-(3-pyrrolidin-1-ylpropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C)C1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCCN1CCCC1 XHKJVYYAWRNGMP-UHFFFAOYSA-N 0.000 description 1
- FMVOURDWJTWGJY-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-[2-(dimethylamino)ethyl]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCN(C)C)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 FMVOURDWJTWGJY-UHFFFAOYSA-N 0.000 description 1
- WQYROFZABHIYHR-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-[3-(methylamino)propyl]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCCNC)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 WQYROFZABHIYHR-UHFFFAOYSA-N 0.000 description 1
- PINHDQLWFRTEAC-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-[3-[ethyl(methyl)amino]propyl]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(CCCN(C)CC)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 PINHDQLWFRTEAC-UHFFFAOYSA-N 0.000 description 1
- YVNQTZDRZVQVNB-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-1-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=C2N(C)C(N(C)C)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 YVNQTZDRZVQVNB-UHFFFAOYSA-N 0.000 description 1
- DGZZPMYTTUOKMZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-(2-hydroxyethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2N(CCO)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 DGZZPMYTTUOKMZ-UHFFFAOYSA-N 0.000 description 1
- WMGDWCQQRNXXHK-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-(2-methoxyethyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2N(CCOC)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 WMGDWCQQRNXXHK-UHFFFAOYSA-N 0.000 description 1
- HTDHTUJLCGKXLV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-(3-hydroxypropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2N(CCCO)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 HTDHTUJLCGKXLV-UHFFFAOYSA-N 0.000 description 1
- IZFNEVXGRRTBAV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-[2-(dimethylamino)ethyl]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1=C2N(CCN(C)C)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 IZFNEVXGRRTBAV-UHFFFAOYSA-N 0.000 description 1
- KRSARQCMBBEXMH-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(dimethylamino)-3-propylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1=C2N(CCC)C(N(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 KRSARQCMBBEXMH-UHFFFAOYSA-N 0.000 description 1
- AEWJPRKRFJXQJV-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(methylamino)-1-phenylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CNC1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1C1=CC=CC=C1 AEWJPRKRFJXQJV-UHFFFAOYSA-N 0.000 description 1
- LNCTUDLOPTYSMI-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(methylaminomethyl)quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC2=NC(CNC)=CC=C2C=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 LNCTUDLOPTYSMI-UHFFFAOYSA-N 0.000 description 1
- QUPILHSZFLDDLG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(morpholin-4-ylmethyl)-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=C(CN4CCOCC4)SC3=CC=1)C=N2 QUPILHSZFLDDLG-UHFFFAOYSA-N 0.000 description 1
- PVFOJNGXRJKDMG-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(piperidin-1-ylmethyl)-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=C(CN4CCCCC4)SC3=CC=1)C=N2 PVFOJNGXRJKDMG-UHFFFAOYSA-N 0.000 description 1
- HYJDZUVIJDAGNE-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-(pyrrolidin-1-ylmethyl)-3,4-dihydro-2h-1,4-benzoxazin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3NCC(CN4CCCC4)OC3=CC=1)C=N2 HYJDZUVIJDAGNE-UHFFFAOYSA-N 0.000 description 1
- RJPPIDAXEMYCJF-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(2,2,6,6-tetramethylpiperidin-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound CC1(C)CCCC(C)(C)N1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=N1 RJPPIDAXEMYCJF-UHFFFAOYSA-N 0.000 description 1
- QUAXDVSEAPHPJN-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(3-oxopyrrolidin-1-yl)methyl]quinolin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(CN4CC(=O)CC4)=NC3=CC=1)C=N2 QUAXDVSEAPHPJN-UHFFFAOYSA-N 0.000 description 1
- LMTZZVFDMYFEHC-LMOVPXPDSA-N 6-(4-chlorophenyl)-3-[2-[(3s)-3-hydroxypyrrolidin-1-yl]-3-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2N(C)C(N3C[C@@H](O)CC3)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 LMTZZVFDMYFEHC-LMOVPXPDSA-N 0.000 description 1
- RCVZWTDSDJVWOI-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-methylpiperazin-1-yl)methyl]-3,4-dihydro-2h-1,4-benzoxazin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1CN(C)CCN1CC1OC2=CC=C(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C=C2NC1 RCVZWTDSDJVWOI-UHFFFAOYSA-N 0.000 description 1
- QOIDPHCDTNXCDA-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=C(CN4CCN(CC4)C=4C=CC=CC=4)SC3=CC=1)C=N2 QOIDPHCDTNXCDA-UHFFFAOYSA-N 0.000 description 1
- NRMDDYSFIYWXTP-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(4-phenylpiperidin-1-yl)methyl]-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=C(CN4CCC(CC4)C=4C=CC=CC=4)SC3=CC=1)C=N2 NRMDDYSFIYWXTP-UHFFFAOYSA-N 0.000 description 1
- XJMIODNDCXPYKT-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]-1-benzothiophen-5-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2SC(CN(C)C)=CC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 XJMIODNDCXPYKT-UHFFFAOYSA-N 0.000 description 1
- KSKTVNDBBQXHSL-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]-3,4-dihydro-2h-1,4-benzoxazin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2OC(CN(C)C)CNC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 KSKTVNDBBQXHSL-UHFFFAOYSA-N 0.000 description 1
- HXWVPBIAJVNCAE-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2NC(CN(C)C)=NC2=CC=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 HXWVPBIAJVNCAE-UHFFFAOYSA-N 0.000 description 1
- NYCMABQJWBVKHY-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[2-methoxyethyl(methyl)amino]-1-methylbenzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O.C=1C=C2N(C)C(N(C)CCOC)=NC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 NYCMABQJWBVKHY-UHFFFAOYSA-N 0.000 description 1
- JVKLGKRIQJGSJZ-MRTLOADZSA-N 6-(4-chlorophenyl)-3-[2-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1[C@H](O)CCN1CC1OC2=CC=C(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C=C2OC1 JVKLGKRIQJGSJZ-MRTLOADZSA-N 0.000 description 1
- LZNGOWRILRYSPJ-MRTLOADZSA-N 6-(4-chlorophenyl)-3-[2-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]-3,4-dihydro-2h-1,4-benzoxazin-6-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1[C@H](O)CCN1CC1OC2=CC=C(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C=C2NC1 LZNGOWRILRYSPJ-MRTLOADZSA-N 0.000 description 1
- SKNZPZRUVKYVNL-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-[methyl(2-pyrrolidin-1-ylethyl)amino]-3h-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.N=1C2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2NC=1N(C)CCN1CCCC1 SKNZPZRUVKYVNL-UHFFFAOYSA-N 0.000 description 1
- ILYMDQJBUQQHOM-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-methyl-1-(3-morpholin-4-ylpropyl)benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=NC2=CC(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)=CC=C2N1CCCN1CCOCC1 ILYMDQJBUQQHOM-UHFFFAOYSA-N 0.000 description 1
- MWUGFAVFBYRQMI-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[2-methyl-1-[3-(4-methylpiperazin-1-yl)propyl]benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1CN(C)CCN1CCCN1C2=CC=C(N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C=C2N=C1C MWUGFAVFBYRQMI-UHFFFAOYSA-N 0.000 description 1
- LGQRXFXMSKWBCD-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-(hydroxymethyl)naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC2=CC(CO)=CC=C2C=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 LGQRXFXMSKWBCD-UHFFFAOYSA-N 0.000 description 1
- MLELJHRGOKUEGH-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-[(dimethylamino)methyl]-5,6,7,8-tetrahydronaphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C=1C=C2CC(CN(C)C)CCC2=CC=1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 MLELJHRGOKUEGH-UHFFFAOYSA-N 0.000 description 1
- ZEDILGGMRZGBJX-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-[6-[(dimethylamino)methyl]naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1=CC2=CC(CN(C)C)=CC=C2C=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 ZEDILGGMRZGBJX-UHFFFAOYSA-N 0.000 description 1
- BKDISOTXLZYOGT-HSZRJFAPSA-N 6-(4-chlorophenyl)-3-[6-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]naphthalen-2-yl]thieno[3,2-d]pyrimidin-4-one Chemical compound C1[C@H](O)CCN1CC1=CC=C(C=C(C=C2)N3C(C=4SC(=CC=4N=C3)C=3C=CC(Cl)=CC=3)=O)C2=C1 BKDISOTXLZYOGT-HSZRJFAPSA-N 0.000 description 1
- LOMNCPDMOWHWMC-UHFFFAOYSA-N 6-[(dimethylamino)methyl]naphthalen-2-amine Chemical compound C1=C(N)C=CC2=CC(CN(C)C)=CC=C21 LOMNCPDMOWHWMC-UHFFFAOYSA-N 0.000 description 1
- JKPZFEJDVHCDRI-UHFFFAOYSA-N 6-[6-(4-chlorophenyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]naphthalene-2-carbaldehyde Chemical compound C1=CC(Cl)=CC=C1C(S1)=CC2=C1C(=O)N(C=1C=C3C=CC(C=O)=CC3=CC=1)C=N2 JKPZFEJDVHCDRI-UHFFFAOYSA-N 0.000 description 1
- OPXZJSGFUFISKN-UHFFFAOYSA-N 6-[6-(4-chlorophenyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]naphthalene-2-carboxylic acid Chemical compound C1=CC2=CC(C(=O)O)=CC=C2C=C1N(C(C=1S2)=O)C=NC=1C=C2C1=CC=C(Cl)C=C1 OPXZJSGFUFISKN-UHFFFAOYSA-N 0.000 description 1
- HSEDDANFWUMVCY-UHFFFAOYSA-N 6-nitro-1h-benzimidazol-2-amine Chemical compound C1=C([N+]([O-])=O)C=C2NC(N)=NC2=C1 HSEDDANFWUMVCY-UHFFFAOYSA-N 0.000 description 1
- DDIHBRSLYYKIDQ-UHFFFAOYSA-N 6-nitro-2-(pyrrolidin-1-ylmethyl)quinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN1CCCC1 DDIHBRSLYYKIDQ-UHFFFAOYSA-N 0.000 description 1
- ACDCXROWTQJSBF-UHFFFAOYSA-N 6-nitro-2-[(4-phenylpiperidin-1-yl)methyl]quinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN(CC1)CCC1C1=CC=CC=C1 ACDCXROWTQJSBF-UHFFFAOYSA-N 0.000 description 1
- QMBQXTXZWWUHDK-UHFFFAOYSA-N 6-nitro-2-[[4-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methyl]quinoline Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2N=C1CN(CC1)CCC1C1=CC=C(C(F)(F)F)C=C1 QMBQXTXZWWUHDK-UHFFFAOYSA-N 0.000 description 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- LHFFMAAGRIIVQV-UHFFFAOYSA-N 7-(4-chlorophenyl)-3-[2-[(dimethylamino)methyl]quinolin-6-yl]quinazolin-4-one Chemical compound C1=CC2=NC(CN(C)C)=CC=C2C=C1N(C(C1=CC=2)=O)C=NC1=CC=2C1=CC=C(Cl)C=C1 LHFFMAAGRIIVQV-UHFFFAOYSA-N 0.000 description 1
- KXXVCAUNRXWQND-UHFFFAOYSA-N 7-chloro-3-(2-methylquinolin-6-yl)quinazolin-4-one Chemical compound C1=NC2=CC(Cl)=CC=C2C(=O)N1C1=CC2=CC=C(C)N=C2C=C1 KXXVCAUNRXWQND-UHFFFAOYSA-N 0.000 description 1
- SOIJOIZOKGTWKB-UHFFFAOYSA-N 7-chloro-3-[2-(chloromethyl)quinolin-6-yl]quinazolin-4-one Chemical compound C1=NC2=CC(Cl)=CC=C2C(=O)N1C1=CC2=CC=C(CCl)N=C2C=C1 SOIJOIZOKGTWKB-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000008822 Ankylosis Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- HEYVINCGKDONRU-UHFFFAOYSA-N Bupropion hydrochloride Chemical compound Cl.CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 HEYVINCGKDONRU-UHFFFAOYSA-N 0.000 description 1
- MINMKRROJCYHRM-GFCCVEGCSA-N C=C(c1cc2cc(N)ccc2[s]1)N(CC1)C[C@@H]1O Chemical compound C=C(c1cc2cc(N)ccc2[s]1)N(CC1)C[C@@H]1O MINMKRROJCYHRM-GFCCVEGCSA-N 0.000 description 1
- PMWGIVRHUIAIII-UHFFFAOYSA-N CC(C(O)=O)(F)F Chemical compound CC(C(O)=O)(F)F PMWGIVRHUIAIII-UHFFFAOYSA-N 0.000 description 1
- ZHADONHSXWZCFN-UHFFFAOYSA-N CC(C)(C)OC(N(C)CCCN(C(N(C)C)=C(C)C)c(cc1)c(C)cc1NC)=O Chemical compound CC(C)(C)OC(N(C)CCCN(C(N(C)C)=C(C)C)c(cc1)c(C)cc1NC)=O ZHADONHSXWZCFN-UHFFFAOYSA-N 0.000 description 1
- RIFUMXQSESGTCG-UHFFFAOYSA-N CC(C)C1(NC2=C(N1)C=CC(=C2)N)N Chemical compound CC(C)C1(NC2=C(N1)C=CC(=C2)N)N RIFUMXQSESGTCG-UHFFFAOYSA-N 0.000 description 1
- PQOMGRCQIMUJID-UHFFFAOYSA-N CC(C)Nc1nc2cc([N+]([O-])=O)ccc2[nH]1 Chemical compound CC(C)Nc1nc2cc([N+]([O-])=O)ccc2[nH]1 PQOMGRCQIMUJID-UHFFFAOYSA-N 0.000 description 1
- RDJTVJIPMUUOQU-UHFFFAOYSA-N CC1(N)NC2=C(N1)C=C(N)C=C2 Chemical compound CC1(N)NC2=C(N1)C=C(N)C=C2 RDJTVJIPMUUOQU-UHFFFAOYSA-N 0.000 description 1
- NCWWSCIJSPAYRY-UHFFFAOYSA-N CN(C)C(C[n]1c(N(C)C)nc(cc2)c1cc2[N+]([O-])=O)=O Chemical compound CN(C)C(C[n]1c(N(C)C)nc(cc2)c1cc2[N+]([O-])=O)=O NCWWSCIJSPAYRY-UHFFFAOYSA-N 0.000 description 1
- NHTWNABQXOCFEN-UHFFFAOYSA-N CN(C)Cc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[nH]1 Chemical compound CN(C)Cc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[nH]1 NHTWNABQXOCFEN-UHFFFAOYSA-N 0.000 description 1
- YFHMEABEXVFVDW-UHFFFAOYSA-N CN(C)c1nc(cc(cc2)[NH+]([O-])O)c2[n]1CCO Chemical compound CN(C)c1nc(cc(cc2)[NH+]([O-])O)c2[n]1CCO YFHMEABEXVFVDW-UHFFFAOYSA-N 0.000 description 1
- RJZWWGQFGCBYKV-UHFFFAOYSA-N CN(C)c1nc(ccc(N(C=Nc2c3[s]c(-c(cc4)ccc4Cl)c2)C3=O)c2)c2[n]1CCO Chemical compound CN(C)c1nc(ccc(N(C=Nc2c3[s]c(-c(cc4)ccc4Cl)c2)C3=O)c2)c2[n]1CCO RJZWWGQFGCBYKV-UHFFFAOYSA-N 0.000 description 1
- LZYDDUQGSHJFCD-UHFFFAOYSA-N CN(C)c1nc(ccc([NH+]([O-])[O-])c2)c2[n]1CCO Chemical compound CN(C)c1nc(ccc([NH+]([O-])[O-])c2)c2[n]1CCO LZYDDUQGSHJFCD-UHFFFAOYSA-N 0.000 description 1
- QYNNPPZUYLSACF-UHFFFAOYSA-N CN(C)c1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[n]1CCCOC Chemical compound CN(C)c1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[n]1CCCOC QYNNPPZUYLSACF-UHFFFAOYSA-N 0.000 description 1
- SIIMMSPIDOFBGG-UHFFFAOYSA-N CN(CC1)C(Nc2c3)N1c2ccc3N(CNc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O Chemical compound CN(CC1)C(Nc2c3)N1c2ccc3N(CNc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O SIIMMSPIDOFBGG-UHFFFAOYSA-N 0.000 description 1
- VCFOXQKDPZCDJS-UHFFFAOYSA-N CN(CCCO)c1nc(cc(cc2)N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)c2[n]1C Chemical compound CN(CCCO)c1nc(cc(cc2)N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)c2[n]1C VCFOXQKDPZCDJS-UHFFFAOYSA-N 0.000 description 1
- QHBIGTKXNYVNMD-UHFFFAOYSA-N CN(CCOC)c1nc2cc(N)ccc2[n]1C Chemical compound CN(CCOC)c1nc2cc(N)ccc2[n]1C QHBIGTKXNYVNMD-UHFFFAOYSA-N 0.000 description 1
- QLVLECDJPJANHQ-UHFFFAOYSA-N CNc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[nH]1 Chemical compound CNc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[nH]1 QLVLECDJPJANHQ-UHFFFAOYSA-N 0.000 description 1
- IFDZNXZRBHSYCY-UHFFFAOYSA-N COCCCC1(C(C=C(C=C1)[N+](=O)[O-])N)N Chemical compound COCCCC1(C(C=C(C=C1)[N+](=O)[O-])N)N IFDZNXZRBHSYCY-UHFFFAOYSA-N 0.000 description 1
- MIYQNLFTRRTMNL-UHFFFAOYSA-N C[n](c(CN1CCCC1)cc1c2)c1ccc2N(C=Nc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O Chemical compound C[n](c(CN1CCCC1)cc1c2)c1ccc2N(C=Nc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O MIYQNLFTRRTMNL-UHFFFAOYSA-N 0.000 description 1
- LFPJXWPRQOFEMY-KRWDZBQOSA-N C[n](c1c2)c(N(CC3)C[C@H]3O)nc1ccc2N(C=Nc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O Chemical compound C[n](c1c2)c(N(CC3)C[C@H]3O)nc1ccc2N(C=Nc1c2[s]c(-c(cc3)ccc3Cl)c1)C2=O LFPJXWPRQOFEMY-KRWDZBQOSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VCJHMSDWRCFLFD-UHFFFAOYSA-N Cc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)cnc2[n]1CCCN1C[IH]CC1 Chemical compound Cc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)cnc2[n]1CCCN1C[IH]CC1 VCJHMSDWRCFLFD-UHFFFAOYSA-N 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- KDOMFUOLJNBVRI-OQLLNIDSSA-N ClC1=CC=C(C=C1)C1=CC(=CS1)/N=C/N(C)C Chemical compound ClC1=CC=C(C=C1)C1=CC(=CS1)/N=C/N(C)C KDOMFUOLJNBVRI-OQLLNIDSSA-N 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000400611 Eucalyptus deanei Species 0.000 description 1
- CZYYYDWBZQAEIA-UHFFFAOYSA-N FC(C(=O)O)(F)F.ClC1=CC=C(C=C1)C1=CC=2N=CN(C(C2S1)=O)C=1C=C2C=CC(=NC2=CC1)CNC Chemical compound FC(C(=O)O)(F)F.ClC1=CC=C(C=C1)C1=CC=2N=CN(C(C2S1)=O)C=1C=C2C=CC(=NC2=CC1)CNC CZYYYDWBZQAEIA-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000029828 Melanin-concentrating hormone receptor Human genes 0.000 description 1
- 108010047068 Melanin-concentrating hormone receptor Proteins 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- UNDDMTBDOFQGMS-UHFFFAOYSA-N N,1-dimethyl-5-nitro-N-(3-phenylmethoxypropyl)benzimidazol-2-amine Chemical compound CN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1N(C)CCCOCC3=CC=CC=C3 UNDDMTBDOFQGMS-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SLKXGTOMVBNIJZ-UHFFFAOYSA-N N-[6-[(4-hydroxypiperidin-1-yl)methyl]naphthalen-2-yl]-2,2-dimethylpropanamide Chemical compound OC1CCN(CC1)CC=1C=C2C=CC(=CC2=CC1)NC(C(C)(C)C)=O SLKXGTOMVBNIJZ-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- DZRBKVLGDBELFV-UHFFFAOYSA-N N1(CCOCC1)CCC1(C(C=C(C=C1)[N+](=O)[O-])N)N Chemical compound N1(CCOCC1)CCC1(C(C=C(C=C1)[N+](=O)[O-])N)N DZRBKVLGDBELFV-UHFFFAOYSA-N 0.000 description 1
- KIXFIVSXZNBXNM-UHFFFAOYSA-N NC=1N(C2=C(N1)C=CC=C2)[N+](=O)[O-] Chemical compound NC=1N(C2=C(N1)C=CC=C2)[N+](=O)[O-] KIXFIVSXZNBXNM-UHFFFAOYSA-N 0.000 description 1
- OXSMZTRDGVTACF-UHFFFAOYSA-N NCC(C(F)(F)F)=O Chemical compound NCC(C(F)(F)F)=O OXSMZTRDGVTACF-UHFFFAOYSA-N 0.000 description 1
- MRBQLPFDEIEQGP-UHFFFAOYSA-N Nc1ccc2[nH]c(N3CCCC3)nc2c1 Chemical compound Nc1ccc2[nH]c(N3CCCC3)nc2c1 MRBQLPFDEIEQGP-UHFFFAOYSA-N 0.000 description 1
- LDNMFBVTFGBUQE-UHFFFAOYSA-N Nc1ccc2[nH]c(NCCN3CCCC3)nc2c1 Chemical compound Nc1ccc2[nH]c(NCCN3CCCC3)nc2c1 LDNMFBVTFGBUQE-UHFFFAOYSA-N 0.000 description 1
- GFMCSDLGLKAYJQ-UHFFFAOYSA-N Nc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[n]1-c1ccccc1 Chemical compound Nc1nc2cc(N(C=Nc3c4[s]c(-c(cc5)ccc5Cl)c3)C4=O)ccc2[n]1-c1ccccc1 GFMCSDLGLKAYJQ-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- DEILAHSYGAUBQG-UHFFFAOYSA-N O=C(c([s]c(-c(cc1)ccc1Cl)c1)c1N=C1)N1C(C=C1)=CC2C1=CC(CN1CCCC1)=CC2 Chemical compound O=C(c([s]c(-c(cc1)ccc1Cl)c1)c1N=C1)N1C(C=C1)=CC2C1=CC(CN1CCCC1)=CC2 DEILAHSYGAUBQG-UHFFFAOYSA-N 0.000 description 1
- WMGIJMCZOFMTPY-UHFFFAOYSA-N OC(=O)C(F)(F)F.CNc1nc2cc(ccc2[nH]1)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1 Chemical compound OC(=O)C(F)(F)F.CNc1nc2cc(ccc2[nH]1)-n1cnc2cc(sc2c1=O)-c1ccc(Cl)cc1 WMGIJMCZOFMTPY-UHFFFAOYSA-N 0.000 description 1
- DDVFXZIOVDVBOI-UHFFFAOYSA-N OC(=O)C(F)(F)F.Clc1ccc(cc1)-c1cc2ncn(-c3ccc4[nH]c(nc4c3)N3CCCC3)c(=O)c2s1 Chemical compound OC(=O)C(F)(F)F.Clc1ccc(cc1)-c1cc2ncn(-c3ccc4[nH]c(nc4c3)N3CCCC3)c(=O)c2s1 DDVFXZIOVDVBOI-UHFFFAOYSA-N 0.000 description 1
- CQNUEMOUSXKEHY-UHFFFAOYSA-N O[N+](c1ccc2nc(C=O)ccc2c1)=O Chemical compound O[N+](c1ccc2nc(C=O)ccc2c1)=O CQNUEMOUSXKEHY-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JHZCHEBIMQDHGT-UHFFFAOYSA-N [N+](=O)([O-])C=1C=C(C(=CC1)N)N.CN(C1=NC2=C(N1)C=CC(=C2)[N+](=O)[O-])C Chemical compound [N+](=O)([O-])C=1C=C(C(=CC1)N)N.CN(C1=NC2=C(N1)C=CC(=C2)[N+](=O)[O-])C JHZCHEBIMQDHGT-UHFFFAOYSA-N 0.000 description 1
- JQZFPGMPLPZPFE-UHFFFAOYSA-N [N+](=O)([O-])C=1C=CC2=C(C=C(O2)C(=O)N2CCCC2)C1.[N+](=O)([O-])C=1C=CC2=C(C=C(O2)CN2CCCC2)C1 Chemical compound [N+](=O)([O-])C=1C=CC2=C(C=C(O2)C(=O)N2CCCC2)C1.[N+](=O)([O-])C=1C=CC2=C(C=C(O2)CN2CCCC2)C1 JQZFPGMPLPZPFE-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001409 amidines Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical group 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 1
- 229960001058 bupropion Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- PFBUKDPBVNJDEW-UHFFFAOYSA-N dichlorocarbene Chemical group Cl[C]Cl PFBUKDPBVNJDEW-UHFFFAOYSA-N 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- PXOIIZOTNBIMPZ-UHFFFAOYSA-N dichloromethane;oxalyl dichloride Chemical compound ClCCl.ClC(=O)C(Cl)=O PXOIIZOTNBIMPZ-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- DTGUXIWYZIAUIT-UHFFFAOYSA-N ethyl 1-methyl-5-nitroindole-2-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2N(C)C(C(=O)OCC)=CC2=C1 DTGUXIWYZIAUIT-UHFFFAOYSA-N 0.000 description 1
- DVFJMQCNICEPAI-UHFFFAOYSA-N ethyl 5-nitro-1h-indole-2-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2NC(C(=O)OCC)=CC2=C1 DVFJMQCNICEPAI-UHFFFAOYSA-N 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000003468 luciferase reporter gene assay Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- UOZZOCYYLNLMSF-UHFFFAOYSA-N methanamine (6-nitroquinolin-2-yl)methanamine Chemical compound CN.[N+](=O)([O-])C=1C=C2C=CC(=NC2=CC1)CN UOZZOCYYLNLMSF-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- MKIJJIMOAABWGF-UHFFFAOYSA-N methyl 2-sulfanylacetate Chemical compound COC(=O)CS MKIJJIMOAABWGF-UHFFFAOYSA-N 0.000 description 1
- YIBRKYVKVWTHEM-UHFFFAOYSA-N methyl 3-amino-5-(4-fluorophenyl)thiophene-2-carboxylate Chemical compound NC1=C(C(=O)OC)SC(C=2C=CC(F)=CC=2)=C1 YIBRKYVKVWTHEM-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000001620 monocyclic carbocycle group Chemical group 0.000 description 1
- BKIUKKCYXXNBIP-UHFFFAOYSA-N morpholin-4-yl-(5-nitro-1-benzothiophen-2-yl)methanone Chemical compound C=1C2=CC([N+](=O)[O-])=CC=C2SC=1C(=O)N1CCOCC1 BKIUKKCYXXNBIP-UHFFFAOYSA-N 0.000 description 1
- CURJNMSGPBXOGK-UHFFFAOYSA-N n',n'-di(propan-2-yl)ethane-1,2-diamine Chemical compound CC(C)N(C(C)C)CCN CURJNMSGPBXOGK-UHFFFAOYSA-N 0.000 description 1
- XNFVZGQBYDBISA-UHFFFAOYSA-N n,n-dimethyl-1-(6-nitro-1h-benzimidazol-2-yl)methanamine Chemical compound C1=C([N+]([O-])=O)C=C2NC(CN(C)C)=NC2=C1 XNFVZGQBYDBISA-UHFFFAOYSA-N 0.000 description 1
- ZUEMKGSVVSOTDZ-UHFFFAOYSA-N n,n-dimethyl-5-nitro-1-benzothiophene-2-carboxamide Chemical compound [O-][N+](=O)C1=CC=C2SC(C(=O)N(C)C)=CC2=C1 ZUEMKGSVVSOTDZ-UHFFFAOYSA-N 0.000 description 1
- AXIIXYZZFIIOGS-UHFFFAOYSA-N n,n-dimethyl-5-nitro-1-phenylbenzimidazol-2-amine Chemical compound CN(C)C1=NC2=CC([N+]([O-])=O)=CC=C2N1C1=CC=CC=C1 AXIIXYZZFIIOGS-UHFFFAOYSA-N 0.000 description 1
- JYDFEZZIGCAYBA-UHFFFAOYSA-N n,n-dimethyl-6-nitro-1h-benzimidazol-2-amine Chemical compound C1=C([N+]([O-])=O)C=C2NC(N(C)C)=NC2=C1 JYDFEZZIGCAYBA-UHFFFAOYSA-N 0.000 description 1
- NZYUIUZGOFCPLB-UHFFFAOYSA-N n-(2-morpholin-4-ylethyl)-2,4-dinitroaniline Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC=C1NCCN1CCOCC1 NZYUIUZGOFCPLB-UHFFFAOYSA-N 0.000 description 1
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XVBORIGVHAHQHF-UHFFFAOYSA-N n-ethyl-n-methyl-3-(2-methyl-5-nitrobenzimidazol-1-yl)propan-1-amine Chemical compound [O-][N+](=O)C1=CC=C2N(CCCN(C)CC)C(C)=NC2=C1 XVBORIGVHAHQHF-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N oxamic acid Chemical compound NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- XIPFMBOWZXULIA-UHFFFAOYSA-N pivalamide Chemical compound CC(C)(C)C(N)=O XIPFMBOWZXULIA-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 description 1
- 229960003015 rimonabant Drugs 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 238000009491 slugging Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005750 substituted cyclic group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- PTVRCUVHYMGECC-UHFFFAOYSA-N tert-butyl 2-(aminomethyl)piperidine-1-carboxylate Chemical group CC(C)(C)OC(=O)N1CCCCC1CN PTVRCUVHYMGECC-UHFFFAOYSA-N 0.000 description 1
- QYJVBVKFXDHFPQ-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)-n-methylcarbamate Chemical compound NCCN(C)C(=O)OC(C)(C)C QYJVBVKFXDHFPQ-UHFFFAOYSA-N 0.000 description 1
- QKSQWQOAUQFORH-UHFFFAOYSA-N tert-butyl n-[(2-methylpropan-2-yl)oxycarbonylimino]carbamate Chemical compound CC(C)(C)OC(=O)N=NC(=O)OC(C)(C)C QKSQWQOAUQFORH-UHFFFAOYSA-N 0.000 description 1
- GKTQKQTXHNUFSP-UHFFFAOYSA-N thieno[3,4-c]pyrrole-4,6-dione Chemical compound S1C=C2C(=O)NC(=O)C2=C1 GKTQKQTXHNUFSP-UHFFFAOYSA-N 0.000 description 1
- 229940071127 thioglycolate Drugs 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46229203P | 2003-04-11 | 2003-04-11 | |
| PCT/US2004/010518 WO2004092181A1 (en) | 2003-04-11 | 2004-04-06 | Heterocyclic mchr1 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522812A true JP2006522812A (ja) | 2006-10-05 |
| JP2006522812A5 JP2006522812A5 (https=) | 2007-01-25 |
Family
ID=33299933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509727A Pending JP2006522812A (ja) | 2003-04-11 | 2004-04-06 | 複素環mchr1アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060194871A1 (https=) |
| EP (1) | EP1618112A1 (https=) |
| JP (1) | JP2006522812A (https=) |
| AR (1) | AR044011A1 (https=) |
| CA (1) | CA2521832A1 (https=) |
| MX (1) | MXPA05010859A (https=) |
| TW (1) | TW200510429A (https=) |
| WO (1) | WO2004092181A1 (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011502957A (ja) * | 2007-05-11 | 2011-01-27 | コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー | アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物 |
| JP2017523977A (ja) * | 2014-07-28 | 2017-08-24 | ジ インダストリー アンド アカデミック コオペレーション イン チュンハム ナショナル ユニバーシティー(アイエーシー) | 新規なインデン誘導体、その調製方法、及びそれを有効成分として含有する網膜疾患を予防又は処置するための医薬組成物 |
| JP2020518661A (ja) * | 2017-07-19 | 2020-06-25 | シャンドン ルーナン リサーチ インスティテュート オブ コール ケミカル エンジニアリング アンド テクノロジーShandong Lunan Research Institute of Coal Chemical Engineering and Technology | ベンゾイミダゾール系化合物およびその製造方法 |
| JP2023520924A (ja) * | 2020-04-08 | 2023-05-22 | リミックス セラピューティクス インコーポレイテッド | スプライシングを調節するための化合物及び方法 |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7989445B2 (en) | 2005-04-28 | 2011-08-02 | Takeda Pharmaceutical Company Limited | Thienopyrimidone compound |
| WO2007011285A1 (en) * | 2005-07-15 | 2007-01-25 | Astrazeneca Ab | Therapeutic agents |
| WO2007035935A1 (en) * | 2005-09-23 | 2007-03-29 | Coley Pharmaceutical Group, Inc. | METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF |
| CN101273026A (zh) | 2005-09-30 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 作为mch受体拮抗剂的茚满衍生物 |
| US8618115B2 (en) * | 2005-10-26 | 2013-12-31 | Bristol-Myers Squibb Company | Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
| US7745447B2 (en) * | 2005-10-26 | 2010-06-29 | Bristol-Myers Squibb Company | Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists |
| US7553836B2 (en) | 2006-02-06 | 2009-06-30 | Bristol-Myers Squibb Company | Melanin concentrating hormone receptor-1 antagonists |
| KR20080094699A (ko) * | 2006-02-15 | 2008-10-23 | 사노피-아벤티스 | 신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도 |
| EP1987020B1 (en) * | 2006-02-15 | 2012-10-03 | Sanofi | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| JP5225269B2 (ja) * | 2006-06-08 | 2013-07-03 | イーライ リリー アンド カンパニー | 新規なmch受容体アンタゴニスト |
| MX2008015662A (es) * | 2006-06-08 | 2009-01-12 | Lilly Co Eli | Nuevos receptores antagonistas de la hormona concentradora de melanina (mch). |
| US20070299062A1 (en) * | 2006-06-26 | 2007-12-27 | The Procter & Gamble Company | Melanin concentrating hormone antagonists |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| WO2008020799A1 (en) | 2006-08-18 | 2008-02-21 | Astrazeneca Ab | Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists |
| EP2121654A1 (en) | 2007-01-10 | 2009-11-25 | Albany Molecular Research, Inc. | 5-pyridinone substituted indazoles |
| KR20100044225A (ko) | 2007-07-21 | 2010-04-29 | 알바니 몰레큘라 리써치, 인크. | 5-피리디논 치환된 인다졸 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PE20091928A1 (es) | 2008-05-29 | 2009-12-31 | Bristol Myers Squibb Co | Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| TW201040153A (en) | 2009-02-13 | 2010-11-16 | Sanofi Aventis | Novel substituted tetrahydronaphthalenes, process for preparation thereof and use thereof as medicaments |
| UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| HUP1100241A3 (en) | 2011-05-06 | 2013-12-30 | Richter Gedeon Nyrt | Oxetane substituted pyrimidones |
| EP2848621A4 (en) * | 2012-05-10 | 2016-06-01 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| JP6785217B2 (ja) * | 2014-07-31 | 2020-11-18 | インスティチュート パスツール コリア | 2−アミノ−ベンゾイミダゾール誘導体ならびにこれらの5−リポキシゲナーゼおよび/またはプロスタグランジンeシンターゼ阻害剤としての使用 |
| CN106866545B (zh) * | 2017-03-31 | 2019-07-09 | 枣庄学院 | 1-环烷烃-5-硝基-1h-苯并[d]咪唑类化合物及其制备方法 |
| CN109020895B (zh) * | 2018-08-07 | 2020-04-24 | 枣庄学院 | 一种金属催化的1-苄胺基取代苯并咪唑的合成方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001082925A1 (en) * | 2000-04-28 | 2001-11-08 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonists |
| WO2002006245A1 (en) * | 2000-07-05 | 2002-01-24 | Synaptic Pharmarceutical Corporation | Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
-
2004
- 2004-04-06 US US10/552,232 patent/US20060194871A1/en not_active Abandoned
- 2004-04-06 MX MXPA05010859A patent/MXPA05010859A/es unknown
- 2004-04-06 JP JP2006509727A patent/JP2006522812A/ja active Pending
- 2004-04-06 CA CA002521832A patent/CA2521832A1/en not_active Abandoned
- 2004-04-06 WO PCT/US2004/010518 patent/WO2004092181A1/en not_active Ceased
- 2004-04-06 EP EP04759148A patent/EP1618112A1/en not_active Withdrawn
- 2004-04-07 AR ARP040101194A patent/AR044011A1/es not_active Application Discontinuation
- 2004-04-09 TW TW093109839A patent/TW200510429A/zh unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001082925A1 (en) * | 2000-04-28 | 2001-11-08 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonists |
| WO2002006245A1 (en) * | 2000-07-05 | 2002-01-24 | Synaptic Pharmarceutical Corporation | Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011502957A (ja) * | 2007-05-11 | 2011-01-27 | コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー | アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物 |
| JP2017523977A (ja) * | 2014-07-28 | 2017-08-24 | ジ インダストリー アンド アカデミック コオペレーション イン チュンハム ナショナル ユニバーシティー(アイエーシー) | 新規なインデン誘導体、その調製方法、及びそれを有効成分として含有する網膜疾患を予防又は処置するための医薬組成物 |
| US10501473B2 (en) | 2014-07-28 | 2019-12-10 | The Industry & Academic Cooperation In Chungnam National University (Iac) | Fused heterocyclic ring compounds and method of treating retinal disease using same |
| JP2020518661A (ja) * | 2017-07-19 | 2020-06-25 | シャンドン ルーナン リサーチ インスティテュート オブ コール ケミカル エンジニアリング アンド テクノロジーShandong Lunan Research Institute of Coal Chemical Engineering and Technology | ベンゾイミダゾール系化合物およびその製造方法 |
| JP2023520924A (ja) * | 2020-04-08 | 2023-05-22 | リミックス セラピューティクス インコーポレイテッド | スプライシングを調節するための化合物及び方法 |
| JP7797407B2 (ja) | 2020-04-08 | 2026-01-13 | リミックス セラピューティクス インコーポレイテッド | スプライシングを調節するための化合物及び方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AR044011A1 (es) | 2005-08-24 |
| WO2004092181A1 (en) | 2004-10-28 |
| TW200510429A (en) | 2005-03-16 |
| EP1618112A1 (en) | 2006-01-25 |
| US20060194871A1 (en) | 2006-08-31 |
| CA2521832A1 (en) | 2004-10-28 |
| MXPA05010859A (es) | 2005-12-14 |
| WO2004092181A9 (en) | 2005-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006522812A (ja) | 複素環mchr1アンタゴニスト | |
| EP1442025B1 (en) | Pyrimidinones as melanin concentrating hormone receptor 1 | |
| JP7817170B2 (ja) | 小分子stingアンタゴニスト | |
| CA2312885C (en) | 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof | |
| CA2740262C (en) | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands | |
| US20100056515A1 (en) | Benzimidazole compounds | |
| CZ281511B6 (cs) | Benzimidazolonové deriváty jako 5-HT1A a 5-HT2 antagonisté | |
| WO2023057414A1 (en) | Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators | |
| KR20140014173A (ko) | 오렉신 길항제로서 유용한 신규 피라졸 및 이미다졸 유도체 | |
| CN107406428B (zh) | Fyn激酶抑制剂 | |
| JP2010528037A (ja) | 5−ht6受容体親和性を有する4’置換化合物 | |
| JP2010519226A (ja) | 5−ht6受容体親和性を有する6’位置換インドール及びインダゾール誘導体 | |
| CA2417082C (en) | New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors | |
| US20170239237A1 (en) | Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof | |
| WO2000055143A1 (en) | Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators | |
| JP4887368B2 (ja) | 新規ヘテロ環化合物 | |
| KR20240046742A (ko) | 소분자 sting 길항제 | |
| US7285557B2 (en) | Pyrimidinones as melanin concentrating hormone receptor 1 | |
| KR102653543B1 (ko) | 알파2c 길항제로서의 2-(1-헤테로아릴피페라진-4-일)메틸-1,4-벤조디옥산 유도체 | |
| AU2002335004A1 (en) | Pyrimidinones as melanin concentrating hormone receptor 1 | |
| HK1158647B (en) | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazo as 5-hydroxytryptamine-6 ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061201 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061201 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100330 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100907 |